Press Release

Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

Angel Pharmaceuticals Announces Approval of IND Application for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China

2022-09-27

Angel Pharmaceuticals Announces Approval of IND Ap...

Angel Pharmaceuticals Appoints Dr. Erik J. Verner, Ph.D., as Senior Vice President

Angel Pharmaceuticals Appoints Dr. Erik J. Verner, Ph.D., as Senior Vice President

2022-03-17

Angel Pharmaceuticals Appoints Dr. Erik J. Verner,...

Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818

Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818

2021-10-26

Angel Pharmaceuticals Announces Approval of IND Ap...

Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China

Angel Pharmaceuticals Announces IND Acceptance for Clinical Trial of ITK Inhibitor CPI-818 in China

2021-08-17

Angel Pharmaceuticals Announces IND Acceptance for...

"Create the new trends together, reach the new medicine world" Angel pharmaceuticals R&D center officially launched!

"Create the new trends together, reach the new medicine world" Angel pharmaceuticals R&D center officially launched!

2021-08-12

Angel Pharmaceuticals is a newly established innov...

Angel Pharmaceuticals Launches with 280 Million Financing by Local Partners and Strategic Collaboration with Corvus Pharmaceuticals

Angel Pharmaceuticals Launches with 280 Million Financing by Local Partners and Strategic Collaboration with Corvus Pharmaceuticals

2021-08-02

Angel Pharmaceuticals Launches with 280 Million Fi...